Emory University
Clinical trials sponsored by Emory University, explained in plain language.
-
Booster shot study aims to strengthen meningitis b protection in young adults
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at whether a single booster dose of a meningitis B vaccine can protect young adults who got a different meningitis B vaccine at least 2.5 years ago. Researchers will measure immune responses in 125 healthy participants before and after the booster. The goal is to…
Phase: PHASE4 • Sponsor: Emory University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:06 UTC
-
Baby stem cells injected to fix failing hearts in kids and young adults
Disease control Recruiting nowThis early-stage trial tests whether infusions of stem cells from donated newborn tissue are safe for young people aged 4 to 39 with dilated cardiomyopathy, a condition where the heart becomes enlarged and weak. Up to 36 participants will receive three intravenous doses over 30 d…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can community navigators save black Mothers' lives? new trial aims to find out
Disease control Recruiting nowThis study tests whether community-based patient navigators can improve maternal health for Black women in a safety-net health system. 540 pregnant women with unmet social needs will be randomly assigned to receive either standard care or extra support from a navigator from mid-p…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New therapy aims to stop dangerous wandering in kids with autism
Disease control Recruiting nowThis study tests a treatment called FBET to reduce elopement (wandering away) in children aged 4–12 with autism. About 50 children will receive either FBET or usual care at community clinics. Caregivers will help track progress and practice skills at home.
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New telehealth program aims to help autistic kids with bowel accidents
Disease control Recruiting nowThis study tests whether a caregiver-led telehealth program can help autistic children ages 5 to 12 who still have bowel accidents after completing treatment for bedwetting. About 150 children will take part. The program teaches caregivers strategies to manage encopresis, with th…
Phase: PHASE4 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a quick chat in a family planning clinic curb risky drinking and drug use?
Disease control Recruiting nowThis study tests whether a program called SBIRT (Screening, Brief Intervention, and Referral to Treatment) can help people reduce risky alcohol and drug use. About 400 adults visiting family planning clinics will either get SBIRT or usual care. Researchers will track changes in d…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Tailored chemo dosing aims to boost stem cell transplant success in myeloma
Disease control Recruiting nowThis phase 1 trial is testing a new way to dose the chemotherapy drug melphalan for people with multiple myeloma who are getting a stem cell transplant. Instead of a standard dose, the amount is personalized based on each patient's blood levels after a test dose. The goal is to f…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Sleep your way to better blood sugar? new study tests behavioral fix for type 1 diabetes
Disease control Recruiting nowThis study tests whether a 12-week sleep-focused behavioral program can help adults with type 1 diabetes improve their sleep and blood sugar control. Participants learn sleep hygiene, stress management, and routines to target 7-9 hours of quality sleep. The study tracks sleep wit…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Peer support groups aim to boost heart health in stressed farmworker women
Disease control Recruiting nowThis study tests whether a program called Sisters for Heart Health can help farmworker women ages 18-50 reduce stress, feel less isolated, and improve their heart health. Participants will join weekly peer support groups led by trained community health workers for 10 weeks. The s…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New coaching program aims to delay dialysis for black kidney patients
Disease control Recruiting nowThis study tests a kidney health coaching program for Black patients with advanced chronic kidney disease. The goal is to help delay the need for dialysis or prevent early death. Researchers will also use a clinical decision support tool to improve screening and care. About 600 p…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a heart drug help immunotherapy fight breast cancer again?
Disease control Recruiting nowThis phase 2 trial tests whether adding the beta-blocker propranolol to the immunotherapy drug pembrolizumab can help shrink tumors in people with metastatic triple-negative breast cancer that has stopped responding to checkpoint inhibitors. About 37 adults with advanced, unresec…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New combo attack on lung tumors: immunotherapy, radiation, and surgery
Disease control Recruiting nowThis early-phase trial is testing whether combining an immunotherapy drug (atezolizumab) with targeted radiation and surgery is safe for people whose osteosarcoma has come back in the lungs. About 12 participants will receive the drug, radiation to one lung nodule, and then surge…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a drug combo stop smoldering myeloma in its tracks?
Disease control Recruiting nowThis phase 2 trial tests iberdomide, an immunotherapy drug, alone or with dexamethasone in 68 people with intermediate- or high-risk smoldering multiple myeloma. The goal is to see if the treatment can shrink or control the cancer cells and delay progression to active myeloma. Pa…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental combo aims to tackle tough bone cancer
Disease control Recruiting nowThis early-stage trial tests a new drug called tegavivint combined with the chemotherapy gemcitabine in 24 people whose osteosarcoma (a type of bone cancer) has returned or not responded to prior treatment. The main goal is to find the safest dose of tegavivint when given with ge…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New counseling program aims to boost mental health and HIV drug adherence in south african men
Disease control Recruiting nowThis trial tests a program called WeCare, which combines problem-solving therapy with support for taking HIV medication. It is designed for men who have sex with men (MSM) in South Africa. The study will enroll 60 participants to see if the program reduces depression and anxiety,…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gut bacteria swap could disarm superbugs in hospital patients
Disease control Recruiting nowThis study tests whether a microbiome therapy—a capsule of healthy gut bacteria—can reduce drug-resistant bacteria living in the gut of hospitalized patients. About 40 adults who carry these superbugs will receive either the therapy or a placebo. The goal is to see if the treatme…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New study tests safer bleeding control for hemophilia a patients on emicizumab
Disease control Recruiting nowThis phase 3 study is testing whether a low, personalized dose of FEIBA (aPCC) can safely control bleeding in children and adults with hemophilia A who have inhibitors and are already taking emicizumab. The study will measure how well the blood clots after FEIBA is given and trac…
Phase: PHASE3 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug cocktail aims to shrink Hard-to-Treat bladder tumors
Disease control Recruiting nowThis early-phase trial is testing whether combining two drugs—cabozantinib and enfortumab vedotin—can safely treat advanced bladder cancer that has spread. About 32 adults whose cancer worsened after standard treatments will receive the combo. The study aims to find the best dose…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Which breathing aid works best for tiny hearts after surgery?
Disease control Recruiting nowThis study looks at 200 infants under 1 year old who had heart surgery for congenital heart disease. After their breathing tube is removed, they will get one of two standard breathing supports: High Flow Nasal Cannula or Non-Invasive Positive Pressure Ventilation. The goal is to …
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New chemo cocktail shows promise for pancreatic cancer patients before surgery
Disease control Recruiting nowThis study tests whether giving a combination of three chemotherapy drugs (gemcitabine, cisplatin, and nab-paclitaxel) before surgery can help shrink pancreatic tumors and improve outcomes. It includes 36 adults with pancreatic cancer that is either removable or borderline remova…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy aims to halt spread of aggressive breast cancer
Disease control Recruiting nowThis phase II trial tests whether adding high-dose radiation to standard immunotherapy (pembrolizumab) and chemotherapy can help control metastatic triple-negative breast cancer that is PD-L1 positive. About 29 participants with at least two sites of metastatic disease will recei…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New antibody shows promise in shrinking HER2+ colorectal tumors before surgery
Disease control Recruiting nowThis phase II trial tests whether giving zanidatamab before surgery can shrink tumors in people with HER2+ colorectal cancer. About 38 participants will receive the drug intravenously, then undergo surgery. The study measures how much the tumor regresses and whether cancer return…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Heart failure checklist aims to boost lifesaving drug use
Disease control Recruiting nowThis study tests whether giving heart failure patients a one-page checklist of recommended medications helps doctors prescribe them more often. The checklist lists guideline-approved drugs and doses for heart failure with reduced ejection fraction. Researchers will enroll 4000 pa…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a simple protein help kids fight COVID-19?
Disease control Recruiting nowThis study tests whether giving arginine (a natural protein) by IV can improve how cells produce energy in children hospitalized with COVID-19. About 21 kids aged 3 to 21 will receive one of three doses three times a day for up to five days. Researchers will measure changes in mi…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for Hard-to-Treat lung cancer: drug cocktail targets resistant tumors
Disease control Recruiting nowThis study tests a combination of two targeted drugs (defactinib and avutometinib) plus an immunotherapy (nivolumab) in people with a specific type of advanced lung cancer (LKB1-mutant adenocarcinoma) that has stopped responding to standard treatment. The goal is to see if this t…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug cocktail aims to outsmart lung cancer resistance
Disease control Recruiting nowThis early-stage trial tests a new drug called MRX-2843 combined with the standard targeted therapy osimertinib in people with advanced EGFR-mutant non-small cell lung cancer. The goal is to find the safest dose and see if the combination can stop tumor growth by blocking key enz…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Brain bleed breakthrough? new trial tests early surgery against standard care
Disease control Recruiting nowThis study looks at whether doing a small surgery early to remove blood from a deep brain bleed helps patients more than standard medical care. About 600 adults aged 18 to 70 with a specific type of brain bleed will take part. The goal is to see which approach leads to better rec…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Alzheimer's drug under the microscope: Real-World registry launches
Disease control Recruiting nowThis registry follows 735 people with mild Alzheimer's or mild cognitive impairment who are receiving an FDA-approved anti-amyloid drug (lecanemab) as part of their regular care. Researchers will track changes in memory, daily function, and caregiver needs over time to see how th…
Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Personalized vaccine takes on head and neck cancer in early trial
Disease control Recruiting nowThis early-phase trial tests a personalized vaccine made from a patient's own tumor cells, given alone or with the immunotherapy drug pembrolizumab, for people with head and neck cancer that has returned or spread. The main goals are to check safety, find the best dose, and see i…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Double radiation attack may slow tough gut tumors
Disease control Recruiting nowThis early-phase study tests whether adding focused external radiation (SBRT) before a standard radioactive drug therapy (177Lu-DOTATATE) is safe and effective for people with large, inoperable neuroendocrine tumors of the digestive system. About 15 adults whose tumors have grown…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug cocktail aims to keep childhood cancers at bay
Disease control Recruiting nowThis phase 2 trial tests whether a year-long maintenance regimen of sirolimus (rapamycin) plus low-dose oral chemotherapy and celecoxib can improve 2-year survival without cancer progression in children with high-risk solid tumors. About 55 children and young adults (ages 1–30) w…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Heart-Safe prostate cancer treatment? new trial pits two hormone combos
Disease control Recruiting nowThis study compares two different hormone therapy combinations (leuprolide plus abiraterone vs. relugolix plus abiraterone) in men with advanced prostate cancer who are also receiving radiation therapy. The goal is to see which combination causes less damage to the heart and bloo…
Phase: PHASE3 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New shorter radiation therapy could tame brain tumors
Disease control Recruiting nowThis study tests a shorter course of high-dose proton radiation for people with non-cancerous brain tumors like meningiomas and schwannomas. The goal is to see if fewer treatments can still control tumor growth while reducing side effects and being more convenient. About 70 adult…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can blood transfusions protect pregnant women with sickle cell disease?
Disease control Recruiting nowThis study tests whether giving regular blood transfusions during pregnancy can reduce sickle cell complications and pregnancy-related problems in women with sickle cell disease. About 50 pregnant women will be randomly assigned to receive transfusions or standard care. The goal …
Phase: PHASE4 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug cocktail aims to shrink Hard-to-Treat adrenal tumors
Disease control Recruiting nowThis phase II trial is testing whether combining cabozantinib (a drug that blocks tumor growth and blood vessel formation) with pembrolizumab (an immunotherapy that helps the immune system attack cancer) can shrink tumors in people with advanced adrenocortical carcinoma. The stud…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New proton beam therapy aims to cut side effects in prostate cancer treatment
Disease control Recruiting nowThis study tests a precise type of radiation called proton therapy for men with high-risk prostate cancer that has spread to lymph nodes. The goal is to see if targeting the tumor and nearby lymph nodes with protons causes fewer bowel and urinary side effects than standard radiat…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a common cholesterol drug boost immunotherapy against head and neck cancer?
Disease control Recruiting nowThis phase II trial tests whether adding lovastatin, a common cholesterol-lowering drug, to the immunotherapy pembrolizumab can help shrink tumors in people with head and neck cancer that has returned or spread. The study will enroll 28 adults whose tumors express PD-L1. Research…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Common painkiller could boost immunotherapy in advanced lung cancer
Disease control Recruiting nowThis phase II trial tests whether adding diclofenac, a common anti-inflammatory painkiller, can help control advanced non-small cell lung cancer when immunotherapy alone starts to show signs of failing. About 20 adults whose cancer has progressed while on standard immunotherapy d…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo aims to rev up immune system against lung cancer
Disease control Recruiting nowThis early-phase trial tests whether adding low-dose interleukin-2 (IL-2) to the immunotherapy drug pembrolizumab (Keytruda) can better activate the immune system against stage IV non-small cell lung cancer. The study will enroll 15 people who have not had prior treatment for the…
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo aims to control lymphoma without chemo
Disease control Recruiting nowThis phase 2 trial is testing a combination of two drugs, acalabrutinib and obinutuzumab, in people with untreated follicular lymphoma or other slow-growing non-Hodgkin lymphomas. The goal is to see if this drug pair can shrink tumors and control the disease. About 49 participant…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a painkiller boost immunotherapy in liver cancer?
Disease control Recruiting nowThis phase 2 trial tests whether adding celecoxib (a painkiller) to two immunotherapy drugs (durvalumab and tremelimumab) can help control advanced or metastatic liver cancer. About 39 adults with liver cancer that has spread will receive the combination. The goal is to see if it…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Custom-Made vaccine takes on aggressive breast cancer
Disease control Recruiting nowThis early-phase trial is testing a personalized vaccine made from a patient's own tumor, given alone or with immune-boosting drugs (pembrolizumab or ipilimumab), for triple negative breast cancer. The goal is to see if the vaccine is safe and can train the immune system to attac…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:15 UTC
-
Immune cell combo shows promise for tough childhood cancers
Disease control Recruiting nowThis early-phase trial is testing whether giving children with advanced neuroblastoma or osteosarcoma a special type of immune cell (gamma delta T cells) from a healthy donor, along with several standard cancer drugs, is safe and tolerable. The study will enroll 24 children aged …
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Sleep your way to better blood sugar? new study tests a 12-Week program for type 1 diabetes
Disease control Recruiting nowThis study tests whether a 12-week sleep improvement program can help adults aged 18-40 with type 1 diabetes manage their blood sugar and reduce distress. Participants will receive coaching based on motivational interviewing and behavior change techniques. The study will track sl…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for rare bleeding disorder: experimental drug aims to stop bleeding episodes
Disease control Recruiting nowThis study tests an investigational drug called eptacog beta (SEVENFACT®) in 6 people with Glanzmann Thrombasthenia, a rare inherited bleeding disorder. For the first 3 months, participants use their standard treatments for bleeding; then they switch to the study drug to treat se…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Morning vs. evening: can timing boost melanoma treatment?
Disease control Recruiting nowThis study tests whether giving standard immunotherapy drugs (ipilimumab and nivolumab) in the morning works better than giving them later in the day for people with advanced melanoma that has spread or cannot be removed. About 99 adults with stage IV melanoma will be randomly as…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Precision radiation aims to stop lung cancer return after surgery
Disease control Recruiting nowThis phase 2 trial tests proton beam radiation therapy in 20 adults with non-small cell lung cancer that has spread to chest lymph nodes (N2) and has been surgically removed. Proton therapy targets cancer cells while sparing healthy tissue, potentially reducing recurrence risk. R…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Gut bacteria therapy takes on superbugs in new trial
Disease control Recruiting nowThis study tests whether giving a special mix of gut bacteria (microbiota therapy) can safely reduce the amount of drug-resistant germs living in the gut. About 60 adults who carry these superbugs will either receive the treatment or be observed. The goal is to see if the therapy…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New program aims to speed healing of diabetic foot ulcers
Disease control Recruiting nowThis study tests a program called CARE-D-Foot-Nav, where a diabetes educator acts as a personal navigator for people with diabetic foot ulcers. The navigator helps with blood sugar control, wound care, transportation, and emotional support. Researchers want to see if this extra h…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Mindfulness and nerve stimulation tested for kidney disease
Disease control Recruiting nowThis study tests whether mindfulness meditation and a mild nerve stimulation device can improve nerve function and blood pressure in people with chronic kidney disease. About 150 participants with moderate kidney disease will take part. The goal is to see if these approaches can …
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Rural ERs get a lifeline: poison center telehealth aims to start opioid treatment on the spot
Disease control Recruiting nowThis study tests a new way to help people with opioid use disorder in rural Georgia. Emergency rooms will use video calls to connect patients with poison center doctors who can start medication (buprenorphine) and link them to peer recovery coaches. The goal is to see if this app…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can a wearable sensor beat fingersticks for hospital diabetes care?
Disease control Recruiting nowThis study tests whether using a Dexcom G7 continuous glucose monitor (CGM) instead of standard fingerstick blood sugar checks leads to better blood sugar control and fewer dangerous lows in hospitalized adults with type 1 diabetes. One hundred participants will be randomly assig…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Electric field therapy for brain tumors: a new hope?
Disease control Recruiting nowThis study tests the safety of a wearable device called Optune that creates low-intensity electric fields to disrupt cancer cell division in brainstem gliomas. Ten adults with this rare brain tumor will wear the device to see if it can slow tumor growth without serious side effec…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Immunotherapy after surgery may keep colon cancer from returning
Disease control Recruiting nowThis trial tests whether the immunotherapy drug toripalimab can lower the chance of cancer coming back after surgery in people with mismatch repair deficient (dMMR) stage IIB, IIC, or III colon cancer. About 40 participants will receive toripalimab intravenously. The study will t…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Old drug, new hope: atovaquone tested against tough ovarian cancer
Disease control Recruiting nowThis phase II trial tests whether atovaquone, a drug currently used to treat certain infections, can help control platinum-resistant ovarian cancer. The study enrolls 28 patients whose cancer has progressed within six months of their last platinum-based chemotherapy. Participants…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 26, 2026 16:38 UTC
-
New cocktail aims to keep High-Risk myeloma at bay
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of belantamab mafodotin, pomalidomide, and dexamethasone can help prevent high-risk myeloma from returning after a stem cell transplant. About 34 patients who have already responded to transplant will receive the drug combo as m…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 26, 2026 13:22 UTC
-
Can a simple eye-tracking test spot autism in babies before their first birthday?
Diagnosis Recruiting nowThis study is testing whether a portable eye-tracking device can accurately screen 9-month-old infants for autism spectrum disorder (ASD). Over 2,000 babies will watch short videos while cameras track their eye movements. Researchers will then compare these results with standard …
Sponsor: Emory University • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Could your smartwatch predict a stroke?
Diagnosis Recruiting nowThis study tests whether a smartwatch algorithm can detect atrial fibrillation (AF), an irregular heartbeat that often goes unnoticed and raises stroke risk. Researchers will enroll 500 stroke survivors who will wear a standard heart monitor and a study-provided smartwatch for 30…
Sponsor: Emory University • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
New light scanner could spot skin cancer without a knife
Diagnosis Recruiting nowThis study tests a new, non-invasive imaging device that uses red light to look at skin lesions. Researchers want to see if it can help doctors diagnose skin cancer without needing a biopsy. The study will enroll 10 adults with skin lesions at Emory University.
Phase: NA • Sponsor: Emory University • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Blood test may spare thousands from unnecessary head scans
Diagnosis Recruiting nowThis study looks at whether a simple blood test can help doctors decide if a head CT scan is really needed after a mild head injury. Researchers will collect blood samples from 350 adults with mild head trauma and see if the test results match the need for imaging. The goal is to…
Phase: NA • Sponsor: Emory University • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Brain zaps after trauma may stop PTSD before it starts
Prevention Recruiting nowThis study tests whether a non-invasive brain stimulation technique called TMS, given within two weeks of a traumatic event, can prevent chronic PTSD. Researchers will measure changes in brain activity linked to fear and threat. The goal is to see if early intervention can reduce…
Phase: NA • Sponsor: Emory University • Aim: Prevention
Last updated Jul 01, 2026 22:00 UTC
-
Can Smoke-Free homes prevent cancer in tribal communities?
Prevention Recruiting nowThis study tests a program to help tribal households go smoke-free, aiming to reduce secondhand smoke exposure and prevent tobacco-related cancers. About 575 adults who smoke or live with a smoker and do not already have a smoke-free home will take part. The program focuses on ch…
Phase: NA • Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
New study tests Parent-Led online sleep therapy for autistic kids
Symptom relief Recruiting nowThis study tests whether a parent-led online program can improve sleep in autistic children aged 3 to 7 years. About 130 children will be randomly assigned to one of two behavioral sleep programs for 10 weeks. The goal is to see if the structured program reduces insomnia symptoms…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could an arthritis drug spark motivation in schizophrenia?
Symptom relief Recruiting nowThis study tests whether infliximab, an anti-inflammatory drug used for arthritis, can improve motivation and brain activity in people with schizophrenia who have high inflammation. Sixty adults with schizophrenia will receive either infliximab or a placebo, and researchers will …
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Brain scans reveal how talk therapy may ease teen depression
Symptom relief Recruiting nowThis study looks at how Behavioral Activation (BA) therapy affects the brains of depressed teenagers. 136 teens aged 15-17 with depression will receive up to 16 therapy sessions focused on increasing rewarding activities. Researchers will use brain scans (fMRI) to see if BA thera…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New program aims to remove travel hurdles for cancer patients
Symptom relief Recruiting nowThis study tests a program called TRACT that helps cancer patients with travel to their radiation therapy appointments. Many patients miss or delay treatment due to transportation issues. The program provides navigation support and resources. Researchers will see if it is practic…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Can robot workouts help Parkinson's patients move better?
Symptom relief Recruiting nowThis study tests a robot-guided exercise program for people with mild to moderate Parkinson's disease. Participants will do exercises three times a week for three weeks, either in person or remotely. The goal is to see if the program is safe, doable, and helps improve movement an…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Could a single dose of MDMA supercharge PTSD therapy?
Symptom relief Recruiting nowThis study tests whether a single dose of MDMA, given alongside two weeks of daily exposure therapy, can reduce PTSD symptoms more than therapy alone. About 95 adults with PTSD will take either MDMA or a placebo during one therapy session. Researchers will check symptom changes o…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Can we ditch opioids after surgery? new trial aims to find out
Symptom relief Recruiting nowThis study compares a standard opioid painkiller (oxycodone) to a placebo in people recovering from orthopedic surgery like joint replacements. The goal is to see if a non-opioid pain management plan can control pain just as well. About 80 adults having various orthopedic procedu…
Phase: PHASE3 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Beat the blues: music may boost Seniors' exercise and brain health
Symptom relief Recruiting nowThis study tests whether exercising to beat-accented music helps older adults (65+) with memory concerns stay active and improve thinking skills. Eighty participants will be randomly assigned to a 6-month exercise program with or without special music. The goal is to see if music…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New online program aims to boost stroke recovery and ease caregiver strain
Symptom relief Recruiting nowThis study tests a web-based program called CARE-CITE that teaches family caregivers how to better support stroke survivors with arm exercises at home. The program includes virtual home visits and phone check-ins over four weeks. Researchers will measure improvements in arm funct…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Could a tiny brain zapper ease gulf war Veterans' pain?
Symptom relief Recruiting nowThis study tests whether a non-invasive device that delivers a mild electrical current to the head (cranial electrical stimulation) can reduce pain and other symptoms in veterans with Gulf War Illness. About 130 participants aged 40-80 will receive either real or sham stimulation…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New study tests vibration and breath focus to quiet dissociation
Symptom relief Recruiting nowThis study tests whether gentle chest vibration or breath focus exercises can reduce symptoms of dissociation in people who have experienced trauma. Researchers will measure changes in brain activity and self-reported symptoms over 8 sessions. The goal is to understand if these s…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New study aims to cut opioid use after hip surgery without sacrificing pain relief
Symptom relief Recruiting nowThis study tests whether a pain management plan that limits opioids can help adults who need hip replacement surgery use fewer opioids while still controlling pain well. About 120 people having anterior total hip replacement will be randomly assigned to either the opioid-sparing …
Phase: PHASE3 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Could a gentle brain zap help veterans beat chronic pain?
Symptom relief Recruiting nowThis study is testing whether a painless brain stimulation technique called tDCS can reduce chronic pain in 100 military members and veterans. Participants will receive tDCS while taking part in a behavioral health program, and researchers will track changes in pain levels and da…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Could a tiny dose of naltrexone ease HIV nerve pain without opioids?
Symptom relief Recruiting nowThis study tests whether a low dose of naltrexone, a drug normally used for addiction, can safely reduce chronic nerve pain in people with HIV. About 60 adults with HIV and nerve pain will take the drug for 12 weeks and report their pain levels. The goal is to find a cheaper, non…
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Heart rate training eases IBD stress in teens
Symptom relief Recruiting nowThis study tests a virtual group program that teaches teens with inflammatory bowel disease (IBD) coping skills and heart rate biofeedback to reduce stress, anxiety, and depression. About 128 participants aged 13–18 will be randomly assigned to the program or a waitlist. The goal…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Could a neck device curb opioid withdrawal?
Symptom relief Recruiting nowThis study tests whether a non-invasive device that stimulates the vagus nerve in the neck can reduce withdrawal symptoms in people with opioid use disorder. About 103 participants will stay in the hospital for a week, receive either active or sham stimulation, and have brain sca…
Phase: PHASE3 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Could a 6-Day steroid pill reduce opioid needs after surgery?
Symptom relief Recruiting nowThis study tests whether a 6-day course of the steroid Medrol (methylprednisolone) can lower pain, nausea, and the need for opioid painkillers after foot or ankle surgery. About 180 adults having surgery at Emory will take either the steroid or a placebo, plus a small supply of h…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New sleep program aims to ease insomnia in dementia patients and caregivers
Symptom relief Recruiting nowThis study tests a 6-week videoconference program that teaches sleep-improving skills to older adults with memory loss or dementia and their care partners. About 80 participants will join either individually or together. The goal is to see if the program is practical, acceptable,…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New ankle pain shot could cut opioid use after surgery
Symptom relief Recruiting nowThis study compares two numbing medicines given as nerve blocks before total ankle replacement surgery. One is EXPAREL, a long-acting form of bupivacaine, and the other is standard bupivacaine. Researchers want to see if EXPAREL provides better pain relief and reduces the need fo…
Phase: PHASE3 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Brain tumor patients may get fewer steroid side effects with tapered dosing
Symptom relief Recruiting nowThis study tests whether slowly reducing the dose of the steroid dexamethasone after brain tumor surgery can lower side effects like high blood sugar and poor wound healing, while still preventing brain swelling. About 200 adults with certain brain tumors will be randomly assigne…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New study aims to reduce allergic reactions in stem cell therapy for multiple myeloma
Symptom relief Recruiting nowThis study tests whether methylprednisolone works better than dexamethasone at preventing allergic reactions to motixafortide, a drug used to help collect stem cells for transplant in multiple myeloma patients. About 94 adults with multiple myeloma will be randomly assigned to re…
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New program aims to ease trauma in black trans women facing stigma
Symptom relief Recruiting nowThis study tests a behavioral program designed to reduce psychological distress (PTSD and depression) in Black transgender women who experience chronic stigma. The program includes weekly group sessions led by a community member and a nurse, plus online educational materials and …
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Nerve block may ease radiation pain for anal cancer patients
Symptom relief Recruiting nowThis study tests a nerve block called ganglion impar neurolysis to see if it can reduce pain caused by radiation therapy for anal cancer. Five adults with localized anal cancer who are getting chemotherapy and radiation will receive the nerve block. Researchers will track pain sc…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Acupuncture may help black women avoid debilitating joint pain during breast cancer treatment
Symptom relief Recruiting nowThis study tests whether in-person acupuncture or virtual acupressure can prevent joint pain caused by aromatase inhibitors, a common hormone therapy for breast cancer. It focuses on Non-Hispanic Black women with early-stage breast cancer, who are more likely to stop treatment du…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could a Parkinson's drug help depressed people feel pleasure again?
Symptom relief Recruiting nowThis study tests whether L-DOPA, a drug used for Parkinson's, can improve anhedonia (loss of interest or pleasure) in people with depression who also have high inflammation. Seventy adults aged 25-55 will receive either L-DOPA or a placebo for 8 weeks. Researchers will measure ch…
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Ear zap could replace pills for sickle cell pain in kids
Symptom relief Recruiting nowThis study tests a small device that gently stimulates nerves in the ear to see if it can help relieve pain in children with sickle cell disease during a pain crisis. About 20 children hospitalized for pain will try the device. The main goal is to see if kids can tolerate it and …
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
New online course could ease the burden for dementia caregivers
Symptom relief Recruiting nowThis study tests an online program called CAN-DO that teaches dementia caregivers skills to handle healthcare, financial, legal, and family issues. 270 caregivers will take the course either right away or after a wait, and complete surveys over 6 months. The goal is to see if the…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Virtual workouts may boost brain power in young cancer survivors
Symptom relief Recruiting nowThis study tests a virtual, home-based exercise program for teens and young adults who had a brain tumor and received radiation. The goal is to see if the program helps with memory and attention problems, and how it affects gut bacteria. About 60 participants will be randomly ass…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Progesterone pills could boost mental health in transgender women
Symptom relief Recruiting nowThis study tests whether taking oral progesterone (200 mg daily) can reduce psychological distress in transgender women who have been on hormone therapy for at least 6 months. It also looks at effects on sleep, breast size, quality of life, and heart health. About 40 participants…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Online game nights could combat loneliness in seniors with memory issues
Symptom relief Recruiting nowThis study tests whether playing online games like Connect 4 and Uno with a partner three times a week for 12 weeks can help older adults (ages 50-85) with and without mild cognitive impairment feel less lonely and more socially engaged. Participants will play via a special onlin…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New online tool aims to ease Cancer's hidden toll on patients and families
Symptom relief Recruiting nowThis study tests a web-based program designed to help people with colorectal cancer and their caregivers manage common but distressing symptoms like fatigue, depression, sleep problems, pain, and brain fog. The program is for patients currently on chemotherapy and their main fami…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Mind over muscle: new study tests mindfulness for injured college athletes
Symptom relief Recruiting nowThis study looks at whether mindfulness training can improve recovery for college athletes who need surgery for sports injuries. About 40 athletes aged 18-26 will either get mindfulness training or standard care. Researchers will track pain, physical function, and mental health f…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New telehealth program aims to ease sickle cell pain in teens
Symptom relief Recruiting nowThis study tests a group telehealth program called I-STRONG for teens with sickle cell disease who have chronic pain. The program combines mind-body skills with movement training to help teens cope better and reduce fear of pain. Researchers will enroll 155 teens aged 12-18 to se…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Slow drip, less pain: new study aims to prevent chemo nerve damage
Symptom relief Recruiting nowThis study tests whether giving the chemotherapy drug oxaliplatin over 6 hours instead of the usual 2 hours can prevent or delay nerve damage in people with gastrointestinal cancers. About 60 participants will be randomly assigned to one of two infusion times. The goal is to see …
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New combo aims to ease symptoms in advanced lung cancer
Symptom relief Recruiting nowThis early-phase study tests whether giving palliative radiotherapy together with the drug lurbinectedin is safe for people with extensive-stage small cell lung cancer that has spread beyond the chest. The goal is to relieve symptoms caused by the cancer. About 22 adults whose ca…
Phase: PHASE1 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Shoulder surgery showdown: to cut or not to cut a chest muscle?
Symptom relief Recruiting nowThis study looks at whether releasing a small chest muscle (pectoralis minor) during reverse shoulder replacement helps reduce pain and improve arm movement. About 90 adults getting this surgery will be randomly assigned to have the muscle released or not. Researchers will compar…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Baking soda and bike rides: a new hope for kidney Patients' fatigue?
Symptom relief Recruiting nowThis phase 2 trial tests whether taking sodium bicarbonate pills and doing regular stationary bike exercise can improve exercise capacity in people with chronic kidney disease (CKD). Researchers will enroll 156 adults with CKD, kidney transplant recipients, or healthy controls. P…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New study tests best way to deliver voice therapy for hoarseness
Symptom relief Recruiting nowThis study looks at whether the method of delivering voice therapy affects how well people with voice problems (like muscle tension dysphonia or vocal cord lesions) can communicate over a year. About 120 adults who do not smoke and have not had voice therapy or surgery recently w…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New online course aims to ease the first 100 days of dementia caregiving
Symptom relief Recruiting nowThis study tests an online course for people who have recently become caregivers for a family member or friend with dementia. The program includes weekly video sessions and self-paced materials to help caregivers feel more confident and less stressed. Researchers will measure cha…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Remote therapy shows promise for helping infants with cerebral palsy use their arms better
Symptom relief Recruiting nowThis study looks at whether a special therapy done at home through video calls can help infants with cerebral palsy use their weaker arm more. About 267 babies aged 4 to 13 months will be assigned to different sequences of the therapy or standard care. The goal is to see if the t…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Can online exercise help kids recover after a stem cell transplant?
Symptom relief Recruiting nowThis study tests whether a virtual exercise program can help children and young adults (ages 8-23) recover physical function and quality of life after a stem cell transplant. Participants will have twice-weekly, 30-minute online sessions with a physical therapist for 12 weeks. Th…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 26, 2026 18:53 UTC
-
Can an amino acid boost brain radiation?
Symptom relief Recruiting nowThis early-phase trial tests whether giving the amino acid arginine alongside whole brain radiation is safe and how best to give it (by mouth or IV). Ten adults with cancer that has spread to the brain will receive arginine daily during their 10-day radiation course. The goal is …
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 26, 2026 18:28 UTC
-
Could an arthritis drug lift the fog of depression?
Symptom relief Recruiting nowThis study tests whether baricitinib, an anti-inflammatory drug used for arthritis, can improve motivation and brain function in people with major depression who have high inflammation. One hundred adults aged 25-55 with depression and elevated C-reactive protein will receive eit…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 26, 2026 17:17 UTC
-
Home workouts may ease cancer Survivors' pain and fatigue
Symptom relief Recruiting nowThis pilot study tests whether an individualized online home-based exercise program can reduce pain, fatigue, sleep problems, depression, and memory issues in gynecologic cancer survivors. Forty women who have finished cancer treatment will follow a tailored exercise plan via Zoo…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 26, 2026 16:44 UTC
-
New catheter maps Heart's electrical secrets to stop lethal rhythms
Knowledge-focused Recruiting nowThis study uses a special catheter to record detailed electrical signals from the heart during a standard procedure for dangerous heart rhythms (ventricular tachycardia). Researchers aim to better understand why these rhythms start and how to pinpoint the exact trouble spots. Ten…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jul 01, 2026 22:00 UTC
-
Massive heart database aims to unlock secrets of cardiovascular disease
Knowledge-focused Recruiting nowThis study creates a large database of about 12,000 people with and without heart disease. Researchers collect medical information and blood samples to analyze factors that influence heart conditions like coronary artery disease, heart failure, and stroke. The goal is to better u…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
5,000 heart patients enrolled in global registry to see if Drug-Coated balloons deliver lasting results
Knowledge-focused Recruiting nowThis registry is following 5,000 adults with coronary artery disease who received a drug-coated balloon during a procedure to open blocked heart arteries. Researchers are tracking how often the treated artery fails, heart attacks, repeat procedures, and bleeding over the long ter…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Math model may unlock diabetes remission secrets
Knowledge-focused Recruiting nowThis study looks at how blood sugar changes day-to-day in people with ketosis-prone diabetes as they go into remission. Researchers will use this data to build a math model that describes the remission process. The study involves 12 African American adults with a BMI of 28 or hig…
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New pilot aims to speed up autism diagnosis for georgia toddlers
Knowledge-focused Recruiting nowThis study is testing a new, quicker way to diagnose autism in toddlers aged 16-30 months who are already flagged as high risk. Researchers will track how many families are referred, agree to join, and complete the process, including a telehealth option. The goal is to see if thi…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Can a simple audio diary app transform diabetes Self-Care?
Knowledge-focused Recruiting nowThis study is testing whether a mobile app called Fabla-diabetesMM, which lets people record audio diaries, is easy and helpful for older adults with type 1 or 2 diabetes who also have other health conditions. Thirty participants will use the app and answer questions about their …
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Music may be the key to getting seniors moving
Knowledge-focused Recruiting nowThis study looks at whether listening to personalized, tempo-synchronous music playlists can help sedentary older adults exercise more and enjoy it. Researchers will track 150 community-dwelling seniors over 8 months as they participate in supervised exercise sessions with music.…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Sugar showdown: could cutting sweets curb CF diabetes?
Knowledge-focused Recruiting nowThis study tests whether a low-added-sugar, high-fat diet can reduce diabetes risk in adults with cystic fibrosis (CF). Sixty participants will receive either a low-sugar or standard CF diet for 8 weeks. Researchers will measure changes in insulin production, body fat, and blood …
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Could an arthritis drug lift depression in HIV patients?
Knowledge-focused Recruiting nowThis study looks at whether inflammation in the brain causes symptoms like loss of interest and slow movement in depressed people with HIV. Sixty participants will receive either the anti-inflammatory drug baricitinib or a placebo for 10 weeks. Researchers will use brain scans an…
Phase: PHASE2 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Ketamine's brain impact under the microscope in depression study
Knowledge-focused Recruiting nowThis study looks at how a single dose of ketamine changes brain chemistry and decision-making in people with major depression. Researchers will measure brain glutamate levels and stress responses in 140 participants. The goal is to understand why ketamine helps some people with d…
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Rural women get boost in cancer genetic screening trial
Knowledge-focused Recruiting nowThis study looks at whether a family history screening program can help more women in rural public health clinics get tested for genetic risks linked to breast and ovarian cancer. About 3,200 women over age 25 will take part. The goal is to see if the program increases the number…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Georgia study seeks best training method for autism therapists
Knowledge-focused Recruiting nowThis study aims to find the best way to train early intervention providers to deliver high-quality services to children under 3 with communication delays or autism. Researchers will compare two training models for a program called Project ImPACT, measuring how well therapists lea…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can prism training and electrical stimulation help stroke survivors see and walk better?
Knowledge-focused Recruiting nowThis study looks at whether combining prism adaptation training with electrical stimulation can help people who have had a stroke and have spatial neglect (trouble noticing things on one side). Researchers will measure changes in pointing behavior, brain activity, and walking abi…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Could a common blood pressure drug protect PTSD Patients' hearts?
Knowledge-focused Recruiting nowThis study aims to understand why people with post-traumatic stress disorder (PTSD) have a higher risk of heart disease and high blood pressure. Researchers will measure nerve activity and test whether the drug losartan can lower high adrenaline levels during stress. The study in…
Phase: PHASE2 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Cystic fibrosis study probes link between body fat, muscle, and lung health
Knowledge-focused Recruiting nowThis study looks at how the amount of muscle and fat in the body affects glucose tolerance and lung function in people aged 16-30 with cystic fibrosis. Researchers will use MRI scans and glucose tests to track changes over two years. The goal is to use this information to improve…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can a simple pill help kidney patients exercise better?
Knowledge-focused Recruiting nowThis study looks at why people with chronic kidney disease (CKD) have trouble exercising and often experience high blood pressure during physical activity. Researchers will test whether regular cycling exercise, a drug called Kuvan, or supplements like histidine and beta-alanine …
Phase: PHASE2 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Kidney Patients' exercise struggles under the microscope
Knowledge-focused Recruiting nowThis study looks at why people with chronic kidney disease (CKD) have trouble exercising and why their blood pressure rises during activity. Researchers will measure muscle oxygen and acid levels in 110 veterans with and without CKD. The goal is to understand the body's response,…
Phase: PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
PKU protein puzzle: study seeks personalized diet answers
Knowledge-focused Recruiting nowThis study looks at how much protein adults with PKU need, based on their specific genetic mutation and the special medical foods they eat. Researchers will measure how the body processes a harmless tracer to find the right protein levels. The goal is to improve dietary recommend…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Camp curriculum aims to boost pregnancy outcomes in rare metabolic disorders
Knowledge-focused Recruiting nowThis study looks at whether a special camp that teaches teens and young women with PKU or MSUD about their condition and nutrition can improve their pregnancy outcomes and quality of life. Researchers will compare the results of women who attended the camp to those who did not. T…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Small study aims to predict which breast cancer patients benefit from immunotherapy
Knowledge-focused Recruiting nowThis pilot study is looking at how the immune system responds in people with early-stage triple negative breast cancer who receive standard chemotherapy plus the immunotherapy drug pembrolizumab before surgery. The goal is to see if certain immune markers in the blood or tumor ti…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can compassion training ease burnout for cancer care teams?
Knowledge-focused Recruiting nowThis study tests a new group program called Compassion-Centered Spiritual Health Team Intervention (CCSH-TI) for healthcare workers at a cancer center. The program uses mindfulness and compassion exercises to help staff handle stress and improve teamwork. Researchers will enroll …
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists study leftover heart tissue to unlock secrets of heart cell maturity
Knowledge-focused Recruiting nowThis study uses small pieces of heart tissue removed during necessary surgery in children with congenital heart disease. Researchers want to understand how calcium controls heart cell contraction and how infant heart cells differ from adult ones. They also aim to improve lab-grow…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Doxycycline's hidden effects on inflammation and microbiome under the microscope
Knowledge-focused Recruiting nowThis study is testing whether the antibiotic doxycycline, already used to prevent bacterial STIs after sex, also changes inflammation levels and the natural bacteria in the body. Researchers will enroll 200 men, including those with HIV and those on PrEP, and measure immune marke…
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Remote hearing tests could save cancer Patients' hearing
Knowledge-focused Recruiting nowThis study tests whether offering hearing tests close to home or remotely increases how many head and neck cancer patients get their hearing checked during treatment. Many patients on cisplatin chemotherapy or radiation near the ear can lose hearing, but not all complete recommen…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Vision and balance: new exercise study seeks volunteers
Knowledge-focused Recruiting nowThis study looks at whether a balance exercise called IVA is safe and helpful for adults who have vision problems, with or without inner-ear balance issues. Researchers will compare two groups: people with vision problems only and those with both vision and inner-ear problems. Pa…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Got milk? study asks if it tricks flu tests.
Knowledge-focused Recruiting nowThis study looks at whether drinking pasteurized milk containing harmless, inactive flu virus particles could lead to a positive flu test from a nose or throat swab. Researchers want to help the CDC improve how flu is tracked. About 30 healthy adults aged 18-64 will drink the mil…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Can better conversations about immunotherapy help patients?
Knowledge-focused Recruiting nowThis study looks at how patients and doctors discuss immunotherapy, a type of cancer treatment. Researchers want to find out where patients get their information, what they understand, and how doctors explain it. They will also test if educational videos can help patients learn m…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Can induction stoves clean Cambodia's air? major study launches
Knowledge-focused Recruiting nowThis study aims to find the best ways to help families in Cambodia switch from wood or charcoal stoves to electric induction stoves. Researchers will track stove use and measure home air pollution in 6150 households across 65 villages. The goal is to see if this switch is practic…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Healthy volunteers inhale flu virus to unlock secrets of infection
Knowledge-focused Recruiting nowThis study gives healthy adults a controlled dose of flu virus to see how their immune system responds and how the virus travels through the air. Researchers will track who gets mild to moderate flu symptoms and monitor safety. The goal is to learn more about flu infection, not t…
Phase: PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Brain zap study reveals how DBS shapes impulse control in Parkinson's
Knowledge-focused Recruiting nowThis study looks at how deep brain stimulation (DBS) affects the ability to stop actions in people with Parkinson's disease. Researchers will measure brain waves and behavior during impulse control tasks before, during, and after DBS surgery. The goal is to understand how stimula…
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Smart patch listens for wheezing in kids with asthma
Knowledge-focused Recruiting nowThis study tests a soft, wearable stethoscope that can continuously listen to a child's breathing and detect wheezing, a sign of an asthma attack. Researchers at Emory University will enroll 25 children hospitalized for asthma to wear the device for up to 8 hours. The goal is to …
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New MRI technique could sharpen radiation for Kids' brain tumors
Knowledge-focused Recruiting nowThis study tests whether a special type of MRI, called spectroscopic MRI, can help guide proton therapy for children with high-grade glioma. The MRI maps tumor metabolism without needing a contrast dye. Researchers hope this will allow more precise radiation targeting. About 25 c…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Scientists study walking changes to spot early Alzheimer's
Knowledge-focused Recruiting nowThis study looks at how people with mild cognitive impairment (MCI) and Alzheimer's disease adjust their walking when conditions change, like walking on different surfaces. Researchers will measure walking patterns, memory, and thinking skills in 10 older adults. The goal is to b…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Healthy volunteers inhale flu virus to help scientists fight future outbreaks
Knowledge-focused Recruiting nowThis study gives healthy adults aged 18-49 a controlled dose of the H3N2 flu virus via nasal spray to observe how the immune system fights it and how the virus spreads. Participants stay in the hospital for 8-12 days for close monitoring, with follow-up visits over 5 months. The …
Phase: PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Study probes which nicotine pouches hook users most
Knowledge-focused Recruiting nowThis study looks at how the amount of nicotine and the pH level in nicotine pouches influence how appealing and addictive they feel to young adult users. Researchers will have 84 participants try different pouches and rate their experience. The goal is to help regulators understa…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Can a friendlier message get more patients into research?
Knowledge-focused Recruiting nowThis study tests different message styles sent through the MyChart patient portal to see which one gets more patients interested in joining research studies. Up to 100,000 patients will receive one of several message types, such as a standard neutral message, a positive message, …
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Lymphoma Patients' vaccine response under microscope
Knowledge-focused Recruiting nowThis study looks at how the immune system of people with lymphoma responds to flu and COVID vaccines. Researchers will measure antibody levels and immune cells over time in 200 participants with different types of lymphoma. The goal is to understand how lymphoma and its treatment…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can a simple talk help men with prostate cancer make better choices?
Knowledge-focused Recruiting nowThis study looks at whether an educational supplement—using models and props during a face-to-face interview—can help African-American men newly diagnosed with early-stage prostate cancer better understand their treatment options and side effects. Researchers will interview 210 p…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Stress and the heart: new study targets women with hidden chest pain
Knowledge-focused Recruiting nowThis study looks at how mental stress impacts the small blood vessels of the heart in postmenopausal women with coronary microvascular dysfunction (CMD). Researchers will measure heart activity, stress responses, and daily symptoms in 150 women using imaging, questionnaires, and …
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
PKU drug palynziq under the microscope: what it does to diet and brain
Knowledge-focused Recruiting nowThis study follows 45 people with PKU who are taking Palynziq to see how the drug changes their diet, brain health, and nutrition. Researchers will track protein intake and blood levels over time. The goal is to understand the full impact of Palynziq beyond just lowering phenylal…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Can calming the nerves protect PTSD patients' hearts?
Knowledge-focused Recruiting nowThis study looks at why people with PTSD have a higher risk of heart problems. Researchers will measure nerve activity and test if two daily therapies—a breathing technique or a mild nerve stimulation device—can calm the overactive nervous system. About 120 veterans with and with…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New study aims to uncover triggers of suicide in bipolar patients
Knowledge-focused Recruiting nowThis study looks at why people with bipolar disorder may think about or attempt suicide, focusing on life experiences and biology. Researchers will test a 6-week group program to help reduce these behaviors and improve quality of life. About 130 English-speaking adults with bipol…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Tailored care plans aim to bridge health literacy gap for black prostate cancer survivors
Knowledge-focused Recruiting nowThis study compares a standard survivorship care plan to one tailored for low health literacy in 150 African American men who have finished treatment for localized or limited-spread prostate cancer. The goal is to see if the tailored plan helps them better understand their follow…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Scientists zap brains to uncover Depression's Decision-Making secrets
Knowledge-focused Recruiting nowThis study aims to understand how depression affects decision-making, especially when choices are difficult. Researchers will use brain stimulation techniques (TMS and TI) on 500 participants with depression and healthy controls while they perform game-like tasks. The goal is to …
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Stick-On patch hears swallowing trouble after stroke
Knowledge-focused Recruiting nowThis study is testing a new wearable patch that uses a microphone to listen to swallowing sounds in people who have trouble swallowing after a stroke. The patch is placed on the neck and records sounds during a standard swallowing X-ray test. Researchers will use machine learning…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New study probes muscle fibrosis in swallowing disorder
Knowledge-focused Recruiting nowThis study looks at how muscle scarring in the esophagus relates to swallowing problems in people with achalasia. Researchers will use a special probe and muscle biopsies to measure scarring and muscle function. The goal is to better understand the disease so doctors can treat it…
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New study tracks kids prone to cancer to uncover early warning signs
Knowledge-focused Recruiting nowThis study follows children under 21 who have a genetic condition that raises their risk of developing cancer, along with their relatives. Researchers will collect health information and samples over time to better understand how these cancers develop and how to catch them early.…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Zapping the brain to forget fear: new study targets PTSD prevention
Knowledge-focused Recruiting nowThis study explores whether a non-invasive brain stimulation technique called cTBS can disrupt the consolidation of fear memories shortly after a traumatic event. Researchers will use functional MRI and skin conductance responses to measure changes in brain connections and fear r…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Which PTSD screening works best for pregnant black women? new study aims to find out.
Knowledge-focused Recruiting nowThis study compares two different screening methods for PTSD in pregnant Black women to see which one better improves mental health, use of prenatal and mental health care, and birth outcomes. About 804 Black women in their first trimester who have experienced at least one trauma…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New imaging study aims to spot radiation damage to neck arteries
Knowledge-focused Recruiting nowThis study looks at how radiation therapy for head and neck cancers affects the blood vessels in the neck. Researchers will use two types of PET/CT scans to compare images taken before and after treatment. The goal is to better understand and detect radiation-related vascular dam…
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Breathing new life: can lung volume predict sleep apnea surgery success?
Knowledge-focused Recruiting nowThis study looks at how the amount of air in your lungs affects throat collapse during sleep in people with obstructive sleep apnea (OSA). Researchers will use a special camera to watch the throat while patients are sedated, and try changing lung volume with a chest device or nec…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New program aims to boost mental wellness in ethiopian and eritrean youth
Knowledge-focused Recruiting nowThis study is testing a group program called Weyera to see if it helps Ethiopian and Eritrean young adults (ages 18-29) in Atlanta feel better mentally and emotionally. The program focuses on building resilience and coping skills. Researchers want to know if the program is accept…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New study tracks best ways to treat hemophilia a when standard therapy fails
Knowledge-focused Recruiting nowThis study follows 120 men with hemophilia A who have developed inhibitors (antibodies that block standard treatment). Researchers will observe how doctors manage their condition using different therapies, including immune tolerance induction and newer drugs like emicizumab. The …
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:08 UTC